Two Sigma Advisers’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-30,100
| Closed | -$46.1K | – | 2709 |
|
|
2023
Q1 | $46.1K | Sell |
30,100
-19,100
| -39% | -$29.2K | ﹤0.01% | 2458 |
|
|
2022
Q4 | $82.7K | Buy |
49,200
+7,200
| +17% | +$12.1K | ﹤0.01% | 2317 |
|
|
2022
Q3 | $52K | Sell |
42,000
-10,300
| -20% | -$12.8K | ﹤0.01% | 2372 |
|
|
2022
Q2 | $87K | Buy |
52,300
+200
| +0.4% | +$333 | ﹤0.01% | 2405 |
|
|
2022
Q1 | $128K | Sell |
52,100
-12,900
| -20% | -$31.7K | ﹤0.01% | 2467 |
|
|
2021
Q4 | $243K | Buy |
+65,000
| New | +$243K | ﹤0.01% | 2217 |
|
|
2021
Q1 | – | Sell |
-21,800
| Closed | -$105K | – | 2756 |
|
|
2020
Q4 | $105K | Sell |
21,800
-4,300
| -16% | -$20.7K | ﹤0.01% | 2269 |
|
|
2020
Q3 | $105K | Buy |
26,100
+5,300
| +25% | +$21.3K | ﹤0.01% | 2272 |
|
|
2020
Q2 | $95K | Buy |
+20,800
| New | +$95K | ﹤0.01% | 2365 |
|